4 most recent filings and news items mentioning ADTX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ADTX/news?limit=20"
Pull ADTX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayAditxt, Inc. and Ignite Proteomics plan to amend their note purchase agreement to include Cavalry Fund I SPV I LP and issue Additional Notes. This update modifies the financing structure to accommodate the new investor's participation.
View filing at SEC.gov →Nasdaq upheld the denial of Aditxt's listing request, suspending trading June 25. The move threatens the company's market access ahead of a shareholder vote to finalize a SPAC merger with Ignite Proteomics.
View filing at SEC.gov →Aditxt Inc. amended its note purchase agreement to authorize an additional $6,638,970.55 in senior secured notes. The legal agreement updates terms applicable to all buyers.
View filing at SEC.gov →Aditxt Inc. named Jeffrey M. Busch, former CEO of NYSE-listed Global Medical REIT, as interim CEO effective May 31, 2026, while founder Amro Albanna resigned from all company positions. Busch will lead the company's commercialization strategy for its Ignite Proteomics precision o
View filing at SEC.gov →